Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rectal Metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01329809
What this trial is testing

Neoadjuvant Study of Recombinant Vaccinia Virus to Treat Metastatic Colorectal Carcinoma in Patients Undergoing Complete Resection of Liver Tumors

Who this might be right for
Colorectal Carcinoma
Jennerex Biotherapeutics 2
Testing effectiveness (Phase 2)UnknownNCT03927898
What this trial is testing

Phase II Study of Toripalimab Plus Stereotactic Body Radiotherapy in Colorectal Cancer Patients With Oligometastasis

Who this might be right for
Metastatic Colorectal Cancer
Chinese Academy of Medical Sciences 40
Not applicableEnded earlyNCT00828620
What this trial is testing

Positron Emission Tomography - Computed Tomography (PET-CT) Cetuximab Project

Who this might be right for
Metastatic Colorectal Cancer
Universitaire Ziekenhuizen KU Leuven 21
Testing effectiveness (Phase 2)UnknownNCT05799820
What this trial is testing

QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC

Who this might be right for
Colorectal Carcinoma
Qilu Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT00030342
What this trial is testing

Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer

Who this might be right for
Colorectal CancerKidney Cancer
St. Luke's Medical Center 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04616183
What this trial is testing

LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal CarcinomaMetastatic Rectal Adenocarcinoma+28 more
M.D. Anderson Cancer Center 46
Early research (Phase 1)Study completedNCT05130060
What this trial is testing

A Vaccine (PolyPEPI1018 Vaccine) and TAS-102 for the Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal AdenocarcinomaMetastatic Colorectal Carcinoma+8 more
Mayo Clinic 15
Testing effectiveness (Phase 2)Study completedNCT02337946
What this trial is testing

Safety and Efficacy Study of mFOLFOX6 + Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in Participants With Chemotherapy-naïve Unresectable Advanced Recurrent Colorectal Carcinoma

Who this might be right for
Colorectal Carcinoma
Takeda 164
Testing effectiveness (Phase 2)Study completedNCT00004910
What this trial is testing

Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction

Who this might be right for
Colorectal CancerConstipation, Impaction, and Bowel ObstructionExtrahepatic Bile Duct Cancer+6 more
Northwestern University
Early research (Phase 1)Active Not RecruitingNCT06253520
What this trial is testing

Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer

Who this might be right for
Metastatic Solid CancersColorectal CancerBreast Cancer+4 more
National Cancer Institute (NCI) 210
Not applicableStudy completedNCT02572362
What this trial is testing

Secondary Cancer Risk After Radiation Therapy for Rectal Cancer

Who this might be right for
Neoplasms, Second Primary
Kantonsspital Graubünden 25
Post-approval studies (Phase 4)UnknownNCT00868569
What this trial is testing

Transhepatic Arterial Chemotherapy (TAC) Versus Transcatheter Arterial Chemoembolization (TACE) Plus Folfox4 as the Treatment of Unresectable Liver Metastasis of Colorectal Cancer

Who this might be right for
Liver MetastasisColorectal Cancer
Fudan University 200
Testing effectiveness (Phase 2)Study completedNCT00628810
What this trial is testing

Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Federation Francophone de Cancerologie Digestive 86
Not applicableNot Yet RecruitingNCT07754513
What this trial is testing

Circulating Tumor Extracellular Vesicles for Non-Invasive Monitoring of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 290
Early research (Phase 1)Looking for participantsNCT06783569
What this trial is testing

A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsGastric CancerEsophagogastric Juction Cancer+1 more
JiaRay Group 94
Large-scale testing (Phase 3)Study completedNCT03231722
What this trial is testing

First Line mFOLFOXIRI + PANITUMUMAB vs mFOLFOX + PANITUMUMAB IN RAS AND BRAF WT METASTATIC COLORECTAL CANCER PATIENTS

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 435
Early research (Phase 1)Active Not RecruitingNCT06781983
What this trial is testing

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Innate Pharma 145
Early research (Phase 1)Study completedNCT00873756
What this trial is testing

Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Genentech, Inc. 23
Testing effectiveness (Phase 2)Study completedNCT01661972
What this trial is testing

Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
John Strickler, M.D. 63
Not applicableStudy completedNCT01082757
What this trial is testing

Prevalence of the Mutational Status of V-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) in Metastatic Colorectal Cancer (mCRC) in Argentine Patients

Who this might be right for
Colorectal Neoplasms
Merck KGaA, Darmstadt, Germany 1,524
Next Page